These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4819977)

  • 21. Influence of albumin degradation products (ADP) on the central action of catecholamines.
    Tarasiewicz S; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):691-6. PubMed ID: 1034926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p-Chloroamphetamine. Temporal relationship between psychomotor stimulation and metabolism of brain norepinephrine.
    Strada SJ; Sanders-Bush E; Sulser F
    Biochem Pharmacol; 1970 Sep; 19(9):2621-9. PubMed ID: 5478286
    [No Abstract]   [Full Text] [Related]  

  • 23. The pharmacology of seizures induced by sensitization with low intensity brain stimulation.
    Babington RG; Wedeking PW
    Pharmacol Biochem Behav; 1973; 1(4):461-7. PubMed ID: 4777582
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoamine synthesis and caffeine-induced locomotor activity.
    White BC; Simpson CC; Adams JE; Harkins D
    Neuropharmacology; 1978 Jul; 17(7):511-3. PubMed ID: 151241
    [No Abstract]   [Full Text] [Related]  

  • 25. [Inhibition of tryptophan pyrrolase activity in rat liver by the administration of imipramine and other antidepressants].
    Samsonova ML
    Vopr Med Khim; 1973; 19(2):148-52. PubMed ID: 4707505
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the specificity of 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine and chlorimipramine as amine uptake inhibitors in mice.
    Fuller RW; Perry KW; Snoddy HD; Molloy BB
    Eur J Pharmacol; 1974 Sep; 28(1):233-6. PubMed ID: 4430328
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 28. Importance of catecholamines for the interaction between reserpine and desipramine on body temperature in rats.
    Jori A; Bernardi D
    Pharmacology; 1970; 4(4):235-41. PubMed ID: 5489997
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of amantadine and (+)-amphetamine on motility in rats after inhibition of monoamine synthesis and storage.
    Lassen JB
    Psychopharmacologia; 1973 Feb; 29(1):55-64. PubMed ID: 4695207
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S; Bolle P; Modigh K
    Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of antidepressants, stimulants and depressants in the transition from a fixed ratio to a fixed interval schedule of reinforcement.
    Fundarò A; Cassone MC; Molinengo L
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):57-62. PubMed ID: 6682987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of various tricyclic antidepressants on amine uptake.
    Ishikawa K; Shibanoki S; Kubo T; Watabe S; Matsumoto A; Kogure M
    Eur J Pharmacol; 1986 Jan; 120(1):63-8. PubMed ID: 2936613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of some drugs on the uptake of monoamines and their precursors in the mouse Paneth cells.
    Ahonen A; Pentilä A
    Acta Physiol Scand; 1971 May; 82(1):59-69. PubMed ID: 5314833
    [No Abstract]   [Full Text] [Related]  

  • 34. Activity of centrally acting drugs on amphetamine metabolism.
    Valzelli L; Dolfini E; Tansella M; Garattini S
    J Pharm Pharmacol; 1968 Aug; 20(8):595-9. PubMed ID: 4386545
    [No Abstract]   [Full Text] [Related]  

  • 35. [Aggressiveness of the rat following combined treatment with monomaime oxidase inhibitors and other psychotropic drugs, especially thymoleptics].
    Zetler G; Otten U
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(1):32-54. PubMed ID: 4390354
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of quinupramine on the central monoamine uptake systems and involvement of pharmacokinetics in its pharmacological activities.
    Sakamoto H; Yokoyama N; Nishimoto T; Murai K; Tatsumi H; Kohno S; Ohata K
    Jpn J Pharmacol; 1987 Oct; 45(2):169-75. PubMed ID: 3437586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo inhibition of 3H-noradrenaline uptake by mouse brain slices in vitro.
    Ross SB; Renyi AL
    J Pharm Pharmacol; 1966 May; 18(5):322-3. PubMed ID: 4380004
    [No Abstract]   [Full Text] [Related]  

  • 38. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 39. On the mechanism of 5-hydroxytryptamine release by thymoleptics.
    Carlsson A; Jonason J; Lindqvist M
    J Pharm Pharmacol; 1969 Nov; 21(11):769-73. PubMed ID: 4390836
    [No Abstract]   [Full Text] [Related]  

  • 40. Suppression of play fighting by amphetamine: effects of catecholamine antagonists, agonists and synthesis inhibitors.
    Beatty WW; Costello KB; Berry SL
    Pharmacol Biochem Behav; 1984 May; 20(5):747-55. PubMed ID: 6539920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.